Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
N.J. Holter, J.A. Gengerelli.
Remote recording of physiological data by radio.
Rocky Mountain Med J, 46 (1940), pp. 747-750
[2.]
W. Glasscok, N.J. Holter.
Radioelectrocardiography for medical research.
Electronics, 25 (1952), pp. 126-141
[3.]
N.J. Holter.
Radioelectrocardiography: a new technique for cardiovascular studies.
Ann NY Acad Sci, 65 (1957), pp. 913-920
[5.]
Association for the Advancement of Medical Instrumentation. American National Standard: ambulatory electrocardiographs.
pp. 38
[6.]
D.A. Bragg-Remschel, C.M. Anderson, R.A.L. Winkle.
Frecuency response characteristics of ambulatory ECG monitoring systems and their implications for ST segment analysis.
Am Heart J, 103 (1982), pp. 20-31
[7.]
T.L. Shook, C.W. Balke, P.W. Kotilainen, M. Hubelbank, A.P. Selwyn, P.H. Stone.
Comparison of amplitude-modulated (direct) and frequency-modulated ambulatory techniques for recording ischemic electrocardiographic changes.
Am J Cardiol, 60 (1987), pp. 895-900
[8.]
R.L. Verrier, B.D. Nearing.
Electrophysiologic basis for T wave alternans as an index of vulnerability to ventricular fibrillation.
J Cardiovasc Electrophysiol, 5 (1994), pp. 445-461
[9.]
K. Phadke, D. Mulcahy, K. Fox.
Clinical validation of four solid state ambulatory monitoring devices in detecting shift of the ST segment.
Int J Cardiol, 33 (1991), pp. 445-446
[10.]
G.A. Lanza, M. Lucente, A.G. Rebuzzi, M.C. Cortellessa, S. Tamburi, P. Mancuso, et al.
Accuracy in clinical arrhythmia detection of a real-time Holter system (Oxford Medilog 4500.
J Electrocardiol, 23 (1990), pp. 301-306
[11.]
H.L. Kennedy.
Importance of the standard electrocardiogram in ambulatory (Holter) electrocardiography.
Am Heart J, 123 (1992), pp. 1660-1667
[12.]
G.A. Lanza, M. Mascellanti, M. Placentino, M. Lucente, F. Crea, A. Maseri.
Usefulness of a third Holter lead for detection of myocardial ischemia.
Am J Cardiol, 74 (1994), pp. 1216-1219
[13.]
M.H. Crawford, S.J. Bernstein, P.C. Deedwania, J.P. DiMarco, K.J. Ferrick, A. Garson Jr., et al.
ACC/AHA guidelines for ambulatory electrocardiography: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the guidelines for ambulatory electrocardiography.
Circulation, 100 (1999), pp. 886-893
[14.]
Task Force of the European Society of Cardiology the North American Society of Pacing Electrophysiology. Heart Rate Variability: Standards of Measurement, Physiological Interpretation, and Clinical Use.
Circulation, 93 (1996), pp. 1043-1065
[15.]
J.M. Miller, D.P. Zipes.
Management of the patient with cardiac arrhythmias.
Heart disease: a textbook of cardiovascular medicine. 6th ed, pp. 700-711
[16.]
J.P. DiMarco, J.T. Philbrick.
Use of ambulatory electrocardiographic (Holter) monitoring.
Ann Intern Med, 113 (1990), pp. 53-68
[17.]
T.H. Diamond, R. Smith, D.P. Myburgh.
Holter monitoring: a necessity for the evaluation of palpitations.
S Afr Med J, 63 (1983), pp. 5-7
[18.]
W.N. Kapoor, R. Cha, J.R. Peterson, H.S. Wieand, M. Karpf.
Prolonged electrocardiographic monitoring in patients with syncope. Importance of frequent or repetitive ventricular ectopy.
Am J Med, 82 (1987), pp. 20-28
[19.]
J.T. Bigger Jr., J.L. Fleiss, R. Kleiger, J.P. Miller, L.M. Rolnitzky.
The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.
Circulation, 69 (1984), pp. 250-258
[20.]
Multicenter Post-infarction Research Group. Risk stratification and survival after myocardial infarction.
N Engl J Med, 309 (1983), pp. 331-336
[21.]
S.K. Huang, J.V. Messer, P. Denes.
Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: observations in 35 patients.
Am J Cardiol, 51 (1983), pp. 507-512
[22.]
B.M. Szabo, D.J. Van Veldhuisen, H.J. Crijns, A.C. Wiesfeld, H.L. Hillege, K.I. Lie.
Value of ambulatory electrocardiographic monitoring to identify increased risk of sudden death in patients with left ventricular dysfunction and heart failure.
Eur Heart J, 15 (1994), pp. 928-933
[23.]
L. Fananapazir, D. McAreavey.
Hypertrophic cardiomyopathy: evaluation and treatment of patients at high risk for sudden death.
Pacing Clin Electrophysiol, 20 (1997), pp. 478-501
[24.]
L. Fananapazir, A.C. Chang, S.E. Epstein, D. McAreavey.
Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings.
Circulation, 86 (1992), pp. 730-740
[25.]
P.J. Counihan, L. Fei, Y. Bashir, T.G. Farrell, G.A. Haywood, W.J. McKenna.
Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features.
Circulation, 88 (1993), pp. 1682-1690
[26.]
J.L. Anderson, E.M. Gilbert, B.L. Alpert, R.W. Henthorn, A.L. Waldo, A.K. Bhandari, et al.
Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.
Circulation, 80 (1989), pp. 1557-1570
[27.]
Cardiac Arrhythmia Supresion Trial (CAST) Investigators. Preliminary report; effect of encainida and flecainida on mortality in a randomised trial of arrhythmia supresion after myocardial infarction.
N Eng J Med, 321 (1989), pp. 406-412
[28.]
D.S. Echt, P.R. Liebson, L.B. Mitchell, R.W. Peters, D. Obias-Manno, A.H. Barker, et al.
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
N Engl J Med, 324 (1991), pp. 781-788
[29.]
The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.
N Engl J Med, 327 (1992), pp. 227-233
[30.]
A.P. Hallstrom, J.L. Anderson, M. Carlson, R. Davies, H.L. Greene, J.M. Kammerling, et al.
Time to arrhythmic, ischemic, and heart failure events: exploratory analyses to elucidate mechanisms of adverse drug effects in the Cardiac Arrhythmia Suppression Trial.
Am Heart J, 130 (1995), pp. 71-79
[31.]
J.L. Anderson, E.V. Platia, A. Hallstrom, R.W. Henthorn, T.A. Buckingham, M.D. Carlson, et al.
Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST.
Circulation, 90 (1994), pp. 2843-2852
[32.]
M.J. Begemann, W. Boute.
Heart rate monitoring in implanted pacemakers.
Pacing Clin Electrophysiol, 11 (1988), pp. 1687-1692
[33.]
D.L. Janosik, R.M. Redd, T.A. Buckingham, R.I. Blum, R.D. Wiens, H.L. Kennedy.
Utility of ambulatory electrocardiography in detecting pacemaker dysfunction in the early postimplantation period.
Am J Cardiol, 60 (1987), pp. 1030-1035
[34.]
A.M. Gillis, K.R. Hillier, J.M. Rothschild, M. McDonald, C.A. Simpson, D.G. Wyse.
Ambulatory electrocardiography for the detection of pacemaker lead failure.
Pacing Clin Electrophysiol, 20 (1997), pp. 1274-1282
[35.]
D. Mulcahy, J. Keegan, J. Sparrow, A. Park, C. Wright, K. Fox.
Ischemia in the ambulatory setting: the total ischemic burden: relation to exercise testing and investigative and therapeutic implications.
J Am Coll Cardiol, 14 (1989), pp. 1166-1172
[36.]
J.A. Panza, A.A. Quyyumi, J.G. Diodati, T.S. Callahan, S.E. Epstein.
Prediction of the frequency and duration of ambulatory myocardial ischemia in patients with stable coronary artery disease by determination of the ischemic threshold from exercise testing: importance of the exercise protocol.
J Am Coll Cardiol, 17 (1991), pp. 657-663
[37.]
R. Krittayaphong, P.L. Biles, C.G. Christy, D.S. Sheps.
Association between angina pectoris and ischemic indexes during exercise testing and ambulatory monitoring.
Am J Cardiol, 78 (1996), pp. 266-270
[38.]
J.A. Panza, A.A. Quyyumi, J.G. Diodati, T.S. Callahan, R.O. Bonow, S.E. Epstein.
Long-term variation in myocardial ischemia during daily life in patients with stable coronary artery disease: its relation to changes in the ischemic threshold.
J Am Coll Cardiol, 19 (1992), pp. 500-506
[39.]
M. Dick, D. McFadden, D. Crowley, A. Rosenthal.
Diagnosis and management of cardiac rhythm disorders by transtelephonic electrocardiography in infants and children.
J Pediatr, 94 (1979), pp. 612-615
[40.]
F. Antúnez Segui, M. Pinol Torrent, A. Vives Julines.
Transtelephonic electrocardiography: an alternative to the Holter system.
Med Clin (Barc), 84 (1985), pp. 476-478
[41.]
G. Gabbia, E. Casiglia, C. Martines, D. Marchese, G. Sforza.
The role of the dynamic electrocardiogram in rhythm disorders.
G Clin Med, 69 (1988), pp. 281-284
[42.]
M. Lefevre, J.B. Bouhour.
Rhythm disorders in children.
Soins Cardiol, 3 (1983), pp. 43-46
[43.]
R.C. Dewey, M.A. Capeless, A.M. Levy.
Use of ambulatory electrocardiographic monitoring to identify high-risk patients with congenital complete heart block.
N Engl J Med, 316 (1987), pp. 835-839
[44.]
M. Zardini, R. Yee, R.K. Thakur, G.J. Klein.
Risk of sudden arrhythmic death in the Wolff-Parkinson-White syndrome: current perspectives.
Pacing Clin Electrophysiol, 17 (1994), pp. 966-975
[45.]
A. Yanagisawa, M. Miyagawa, M. Yotsukura, T. Tsuya, C. Shirato, T. Ishihara, et al.
The prevalence and prognostic significance of arrhythmias in Duchenne type muscular dystrophy.
Am Heart J, 124 (1992), pp. 1244-1250
[46.]
P.V. Fragola, M. Luzi, L. Calo, G. Antonini, M. Borzi, D. Frongillo, et al.
Cardiac involvement in myotonic dystrophy.
Am J Cardiol, 74 (1994), pp. 1070-1072
[47.]
J.P. Pfammatter, T. Paul, C. Lehmann, H.C. Kallfelz.
Efficacy and proarrhythmia of oral sotalol in pediatric patients.
J Am Coll Cardiol, 26 (1995), pp. 1002-1007
[48.]
A. Garson Jr..
Dosing the newer antiarrhythmic drugs in children: considerations in pediatric pharmacology.
Am J Cardiol, 57 (1986), pp. 1405-1407
[49.]
G. Fenelon, A. D’Avila, T. Malacky, P. Brugada.
Prognostic significance of transient complete atrioventricular block during radiofrequency ablation of atrioventricular node reentrant tachycardia.
Am J Cardiol, 75 (1995), pp. 698-702
[50.]
D.L. Packer, G.H. Bardy, S.J. Worley, M.S. Smith, F.R. Cobb, R.E. Coleman, et al.
Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction.
Am J Cardiol, 57 (1986), pp. 563-570
[51.]
G. Giraud, P. Puech, H. Letour, et al.
Variations de potentiel liées a l’activité du système de conduction auriculoventriculaire chez l’homme (enregistrement electrocardiographique endocavitaire.
Arch Mal Coeur Vaiss, 53 (1959), pp. 757-763
[52.]
D. Durrer, L. Schoo, R.M. Schuilenburg, H.J. Wellens.
The role of premature beats in the initiation and termination of supraventricular tachycardia in the Wolff-Parkinson-White syndrome.
Circulation, 36 (1967), pp. 644-662
[53.]
P. Coumel, C. Cabrol, A. Fabiato, et al.
Taquicardie par rythme réciproque.
Arch Mal Coeur Vaiss, 60 (1967), pp. 1830-1835
[54.]
M.M. Scheinmann.
Catheter ablation. Present role and projected impact on health care for patients with cardiac arrhytmias.
Circulation, 83 (1991), pp. 1489-1498
[55.]
M. Zhender, A. Geibel, S. Hohnloser, S. Meinertz, H. Just.
Standarization of non-invasive and invasive studies in the assessment of patiens with ventricular arrhythmias.
Cardiac arrhythmias: where to go from here?, pp. 435-455
[56.]
J.P. Dimarco, H. Garan, J.N. Ruskin.
Complications in patients undergoing cardiac electrophysiologic procedures.
Ann Intern Med, 97 (1982), pp. 490-493
[57.]
L.N. Horowitz.
Safety of electrophysiologic studies.
Circulation, 73 (1986), pp. 28-31
[58.]
L.N. Horowitz, H.R. Kay, S.P. Kutalek, K.F. Discigil, C.R. Webb, A.M. Greenspan, et al.
Risks and complications of clinical cardiac electrophysiologic studies: a prospective analysis of 1,000 consecutive patients.
J Am Coll Cardiol, 9 (1987), pp. 1261-1268
[59.]
D.P. Zipes, J.P. DiMarco, P.C. Gillette, W.M. Jackman, R.J. Myerburg, S.H. Rahimtoola, et al.
Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology.
J Am Coll Cardiol, 26 (1995), pp. 555-773
[60.]
W. Mandel, H. Hayakawa, R. Dnazing, H.S. Marcus.
Evaluation of sinoatrial function in man with overdrive suppression.
Circulation, 44 (1971), pp. 59-66
[61.]
H.C. Strauss, A.L. Saroff, J.T. Bigger, E.G. Giardina.
Premature atrial stimulation as a key to the understanding of sinoatrial conduction in man.
Circulation, 47 (1973), pp. 86-93
[62.]
O.S. Narula, N. Shanto, M. Vasquez, W.D. Towne, J.W. Linhart.
A new method for measurement of sinoatrial conduction time.
Circulation, 58 (1978), pp. 706-714
[63.]
B. Strasberg, F. Amat-Y-Leon, R.C. Dhingra, E. Palileo, S. Swiryn, R. Bauernfeind, et al.
Natural history of chronic second-degree atrioventricular nodal block.
Circulation, 63 (1981), pp. 1043-1049
[64.]
R.C. Dhingra, P. Denes, D. Wu, R. Chuquimia, K.M. Rosen.
The significance of second degree atrioventricular block and bundle branch block: observations regarding site and type of block.
Circulation, 49 (1974), pp. 636-638
[65.]
R.C. Dhingra, E. Palileo, B. Strasberg, S. Swiryn, R.A. Bauernfeind, C.R. Wyndham, et al.
Significance of HV interval in 517 patients with cronic bifascicular block.
Ciculation, 64 (1981), pp. 1265-1277
[66.]
M.M. Scheinman, R.W. Peters, M.J. Sauve, J. Desai, J.A. Abbott, J. Cogan, et al.
Value of HQ interval in patients with bundle branch block and the role of permanent pacing.
Am J Cardiol, 50 (1982), pp. 1316-1322
[67.]
R.C. Dhingra, C. Wyndham, R. Bauernfeind, S. Swiryn, P.C. Deedwania, T. Smith, et al.
Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifascicular block.
Circulation, 60 (1979), pp. 1455-1464
[68.]
A. Englund, L. Bergfeldt, M. Rosenqvist.
Pharmacological stress testing of de His-Purkomje system in patients with bifascicular block.
Pacing Clin Electrophysiol, 21 (1998), pp. 1979-1987
[69.]
N.P. DePascuale, M.S. Bruno.
Natural history of combined right bundle branch block and left anterior hemiblock.
Am J Med, 54 (1973), pp. 297-306
[70.]
M.M. Scheinman, D. Basu, M. Hollenberg.
Electrophysiologic studies in patients with persistent atrial tachycardia.
Circulation, 50 (1974), pp. 266-273
[71.]
G.O. Hartler, J.E. Maloney.
Programmed ventricular stimulation in management of recurrent ventricular tachycardia.
Mayo Clin Proc, 52 (1977), pp. 731-740
[72.]
R. García Civera, R. Ruiz Granell, S. Morell Cabedo, R. San Juan Mañez, J. Martínez León, S. Botella Solana, et al.
Estudios electrofisiológicos en pacientes con síncope.
Electrofisiología cardíaca clínica y ablación, pp. 365-374
[73.]
E.S. Brilakis, W.K. Shen, S.C. Hammill, D.O. Hodge, R.F. Rea, N.Y. Lexvold, et al.
Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncope.
Pace Clin Electrophysiol, 24 (2001), pp. 1623-1630
[74.]
A.J. Moss, W.J. Hall, D.S. Cannom, J.P. Daubert, S.L. Higgins, H. Klein, et al.
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia.
N Engl J Med, 355 (1996), pp. 1933-1940
[75.]
A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prytowsky, G. Hafley.
A randomized study of the prevention of sudden death in patients with coronary artery disease.
N Engl J Med, 341 (1999), pp. 1882-1890
[76.]
A.C. Caruso, F.I. Marcus, E.A. Hahn, V.L. Hartz, J.W. Mason.
Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Electrophysiologic Study Versus Electro-magnetic Monitoring.
Circulation, 96 (1997), pp. 1888-1892
[77.]
K.H. Kuck, K.P. Kunze, M. Schluter, C.A. Nienaber, A. Costard.
Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope.
Eur Heart J, 9 (1988), pp. 77-85
[78.]
A.K. Bhandari, W.A. Shapiro, F. Morady, E.N. Shen, J. Mason, M.M. Scheinman.
Electrophysiologic testing in patients with the long QT syndrome.
Circulation, 71 (1985), pp. 63-71
Copyright © 2002. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.